Market Tracker

01/20 5:16pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

32.66
Delayed Data
As of Jan 20
 -1.57 / -4.59%
Today’s Change
8.00
Today|||52-Week Range
63.73
+19.07%
Year-to-Date
5 Healthcare Stocks Poised for Maximum Gains in 2017
Jan 17 / MotleyFool.com - Paid Partner Content
Are Options Traders Betting on a Big Move in Sarepta Therapeutics (SRPT) Stock?
Jan 11 / Zacks.com - Paid Partner Content
Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns
Jan 17 / TheStreet.com - Paid Partner Content
What Sarepta Therapeutics' CEO Said That Made the Stock Soar
Jan 10 / MotleyFool.com - Paid Partner Content
Bullish and Bearish Reversals in the Market
Jan 17 / TheStreet.com - Paid Partner Content
3 Tempting Stocks We're Avoiding
Jan 10 / MotleyFool.com - Paid Partner Content
Is This Going To Be Sarepta Therapeutics' Year?
Jan 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close34.23
Today’s open34.29
Day’s range32.44 - 34.67
Volume2,168,428
Average volume (3 months)3,942,300
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+3.36%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book7.83

Competitors

 Today’s
change
Today’s
% change
AGIOAgios Pharmaceutical...+0.25+0.59%
CBMCambrex Corp+0.04+0.07%
PRTAProthena Corporation...+0.90+1.84%
HCMHutchison China Medi...+0.06+0.43%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Chief Financial Officer &
Senior Vice President
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts